Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
NCT ID: NCT07209254
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
770 participants
INTERVENTIONAL
2026-02-28
2029-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Postpartum Education to Improve Compliance
NCT04486170
Postpartum Weight Retention
NCT02867631
Postpartum Hypertension: Remote Patient Monitoring
NCT03111095
Better Understanding Patient Perspectives of an Educational Tool for Postpartum Hypertensive Patients
NCT06996496
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
NCT05655936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-touch blood pressure management
High-touch blood pressure management
Twelve weeks of text-based home blood pressure monitoring with BP self-management and team-based care
Low-touch blood pressure management
Low-touch blood pressure management
10 days of text-based home blood pressure monitoring
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-touch blood pressure management
Twelve weeks of text-based home blood pressure monitoring with BP self-management and team-based care
Low-touch blood pressure management
10 days of text-based home blood pressure monitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Delivery within 14 days
* Diagnosis of preeclampsia or gestational hypertension with or without severe features during pregnancy or within 14 days postpartum
* Initiation of blood pressure medication prior to hospital discharge and up to 14 days postpartum
* English or Spanish speaking (able to read/understand consent and instructions)
* Has phone texting capabilities
Exclusion Criteria
* Pre-existing cardiovascular disease (including prior myocardial infarction, stroke, heart failure with reduced ejection fraction, ventricular tachycardia, prior cardiac arrest, pacemaker, severe valvular heart disease, or prior cardiac surgery)
* Chronic kidney disease (stage 3 or higher)
* Using ≥3 BP medications at time of enrollment
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Patient-Centered Outcomes Research Institute
OTHER
Jennifer Lewey, MD, MPH
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Lewey, MD, MPH
Assistant Professor of Medicine (Cardiovascular Medicine)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Lewey, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University
New York, New York, United States
The Ohio State University
Columbus, Ohio, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Meaghan McCabe, MPH
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
858860
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.